— Know what they know.
Not Investment Advice

IVVD NASDAQ

Invivyd, Inc.
1W: -10.9% 1M: +3.5% 3M: -0.2% YTD: -66.7% 1Y: -31.8% 3Y: -53.5% 5Y: -98.1%
$0.82
+0.01 (+0.69%)
 
Weekly Expected Move ±21.5%
$0 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $242.2M mcap · 250M float · 2.01% daily turnover · Short 61% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$53M +110.5% ▲
Gross Profit
$50M +109.0% ▲
Operating Income
-$56M +68.6% ▲
Net Income
-$52M +69.1% ▲
EPS (Diluted)
$-0.30 +79.0% ▲
EBITDA
-$53M +69.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$25M$53M
YoY Growth+0.0%+0.0%+0.0%+0.0%+110.5%
Cost of Revenue$0$0$0$2M$4M
Gross Profit$0$0$0$24M$50M
Gross Margin———93.6%93.0%
R&D Expenses$183M$179M$159M$137M$38M
SG&A Expenses$37M$47M$49M$63M$67M
Operating Expenses$227M$248M$213M$201M$105M
Operating Income-$227M-$248M-$213M-$177M-$56M
Operating Margin———-696.8%-104.0%
Interest Expense$0$43M$0$0$0
Income Before Tax-$227M-$241M-$199M-$170M-$52M
Tax Expense$0$0$0$0$0
Net Income-$227M-$241M-$199M-$170M-$52M
Net Margin———-669.4%-98.2%
EPS (Diluted)$-2.11$-2.17$-1.81$-1.43$-0.30
EBITDA-$219M-$226M-$206M-$174M-$53M
Shares Outstanding111M108M110M119M172M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms